| Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study VM Cao-Lormeau, A Blake, S Mons, S Lastère, C Roche, ... The Lancet 387 (10027), 1531-1539, 2016 | 2729 | 2016 |
| Guillain-barre syndrome HJ Willison, BC Jacobs, PA van Doorn The Lancet 388 (10045), 717-727, 2016 | 1680 | 2016 |
| Peripheral neuropathies and anti‐glycolipid antibodies HJ Willison, N Yuki Brain 125 (12), 2591-2625, 2002 | 852 | 2002 |
| Diagnosis and management of Guillain–Barré syndrome in ten steps SE Leonhard, MR Mandarakas, FAA Gondim, K Bateman, MLB Ferreira, ... Nature Reviews Neurology 15 (11), 671-683, 2019 | 796 | 2019 |
| Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy R Hughes, S Bensa, H Willison, P Van Den Bergh, G Comi, I Illa, ... Annals of neurology 50 (2), 195-201, 2001 | 651 | 2001 |
| Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndrome TW Ho, HJ Willison, I Nachamkin, CY Li, J Veitch, H Ung, GR Wang, ... Annals of Neurology: Official Journal of the American Neurological …, 1999 | 410 | 1999 |
| Serum antibodies to gangliosides in Guillain‐Barré syndrome AA Ilyas, HJ Willison, RH Quarles, FB Jungalwala, DR Cornblath, ... Annals of Neurology: Official Journal of the American Neurological …, 1988 | 327 | 1988 |
| Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome S Keddie, J Pakpoor, C Mousele, M Pipis, PM Machado, M Foster, ... Brain 144 (2), 682-693, 2021 | 324 | 2021 |
| Regional variation of Guillain-Barré syndrome AY Doets, C Verboon, B Van Den Berg, T Harbo, DR Cornblath, ... Brain 141 (10), 2866-2877, 2018 | 316 | 2018 |
| The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies HJ Willison, CP O'leary, J Veitch, LD Blumhardt, M Busby, M Donaghy, ... Brain 124 (10), 1968-1977, 2001 | 315 | 2001 |
| Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. HJ Willison, J Veitch, G Paterson, PG Kennedy Journal of Neurology, Neurosurgery & Psychiatry 56 (2), 204-206, 1993 | 299 | 1993 |
| Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model SK Halstead, FMP Zitman, PD Humphreys, K Greenshields, ... Brain 131 (5), 1197-1208, 2008 | 281 | 2008 |
| The immunobiology of Guillain‐Barre syndromes HJ Willison Journal of the Peripheral Nervous System 10 (2), 94-112, 2005 | 271 | 2005 |
| Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system BC Kieseier, R Kiefer, R Gold, B Hemmer, HJ Willison, HP Hartung Muscle & Nerve: Official Journal of the American Association of …, 2004 | 256 | 2004 |
| Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and … CS Goodyear, GM O’Hanlon, JJ Plomp, ER Wagner, I Morrison, J Veitch, ... The Journal of clinical investigation 104 (6), 697-708, 1999 | 252 | 1999 |
| The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis EC Nilsson, RJ Storm, J Bauer, SMC Johansson, A Lookene, J Ångström, ... Nature medicine 17 (1), 105-109, 2011 | 247 | 2011 |
| Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection TW Ho, ST Hsieh, I Nachamkin, HJ Willison, K Sheikh, J Kiehlbauch, ... Neurology 48 (3), 717-724, 1997 | 237 | 1997 |
| Miller Fisher anti‐GQ1b antibodies: α‐Latrotoxin–like effects on motor end plates JJ Plomp, PC Molenaar, GM O'Hanlon, BC Jacobs, J Veitch, MR Daha, ... Annals of Neurology: Official Journal of the American Neurological …, 1999 | 231 | 1999 |
| Guillain–Barré syndrome: a century of progress JA Goodfellow, HJ Willison Nature Reviews Neurology 12 (12), 723-731, 2016 | 229 | 2016 |
| The immunopathogenesis of Miller Fisher syndrome HJ Willison, GM O'Hanlon Journal of neuroimmunology 100 (1-2), 3-12, 1999 | 207 | 1999 |
